223 related articles for article (PubMed ID: 17516915)
1. Peroxisome-proliferator-activated receptors and the control of levels of prostaglandin-endoperoxide synthase 2 by arachidonic acid in the bovine uterus.
Sheldrick EL; Derecka K; Marshall E; Chin EC; Hodges L; Wathes DC; Abayasekara DR; Flint AP
Biochem J; 2007 Aug; 406(1):175-83. PubMed ID: 17516915
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
3. A PPAR-independent pathway to PUFA-induced COX-2 expression.
Derecka K; Sheldrick EL; Wathes DC; Abayasekara DR; Flint AP
Mol Cell Endocrinol; 2008 Jun; 287(1-2):65-71. PubMed ID: 18395968
[TBL] [Abstract][Full Text] [Related]
4. The influence of arachidonic acid metabolites on PPAR and RXR expression in bovine uterine cells.
Szczepańska AA; Łupicka M; Socha BM; Korzekwa AJ
Gen Comp Endocrinol; 2018 Jun; 262():27-35. PubMed ID: 29510153
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor (PPAR) expression in cultured bovine endometrial cells and response to omega-3 fatty acid, growth hormone and agonist stimulation in relation to series 2 prostaglandin production.
MacLaren LA; Guzeloglu A; Michel F; Thatcher WW
Domest Anim Endocrinol; 2006 Mar; 30(3):155-69. PubMed ID: 16154718
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present).
Takada I; Makishima M
Expert Opin Ther Pat; 2020 Jan; 30(1):1-13. PubMed ID: 31825687
[No Abstract] [Full Text] [Related]
7. Peroxisome proliferator-activated receptor alpha, delta, gamma1 and gamma2 expressions are present in human monocyte-derived dendritic cells and modulate dendritic cell maturation by addition of subtype-specific ligands.
Jakobsen MA; Petersen RK; Kristiansen K; Lange M; Lillevang ST
Scand J Immunol; 2006 May; 63(5):330-7. PubMed ID: 16640656
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor β/δ and γ agonists differentially affect prostaglandin E2 and cytokine synthesis and nutrient transporter expression in porcine trophoblast cells during implantation.
Blitek A; Szymanska M
Theriogenology; 2020 Aug; 152():36-46. PubMed ID: 32361305
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptors alpha and beta mediate the anti-inflammatory effects of the cyclopentenone prostaglandin 15-deoxy-Δ
Gómez-Abellán V; Pérez-Oliva AB; Cabas I; Hermi F; Arizcun M; García-Moreno D; Sepulcre MP; Mulero V
Dev Comp Immunol; 2022 Nov; 136():104498. PubMed ID: 35948178
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats.
Sun L; Ke Y; Zhu CY; Tang N; Tian DK; Gao YH; Zheng JP; Bian K
Chin Med J (Engl); 2008 Nov; 121(22):2305-11. PubMed ID: 19080338
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells.
Röhrl C; Kaindl U; Koneczny I; Hudec X; Baron DM; König JS; Marian B
J Cancer Res Clin Oncol; 2011 Jan; 137(1):29-39. PubMed ID: 20221637
[TBL] [Abstract][Full Text] [Related]
12. Do arachidonic acid metabolites affect apoptosis in bovine endometrial cells with silenced PPAR genes?
Szczepańska AA; Łupicka M; Korzekwa AJ
Prostaglandins Other Lipid Mediat; 2019 Aug; 143():106336. PubMed ID: 31112752
[TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
14. PPARs as therapeutic targets in cardiovascular disease.
van Bilsen M; van Nieuwenhoven FA
Expert Opin Ther Targets; 2010 Oct; 14(10):1029-45. PubMed ID: 20854178
[TBL] [Abstract][Full Text] [Related]
15. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate.
Takacs ML; Abbott BD
Toxicol Sci; 2007 Jan; 95(1):108-17. PubMed ID: 17047030
[TBL] [Abstract][Full Text] [Related]
16. A pan-PPAR ligand induces hepatic fatty acid oxidation in PPARalpha-/- mice possibly through PGC-1 mediated PPARdelta coactivation.
Røst TH; Haugan Moi LL; Berge K; Staels B; Mellgren G; Berge RK
Biochim Biophys Acta; 2009 Nov; 1791(11):1076-83. PubMed ID: 19577662
[TBL] [Abstract][Full Text] [Related]
17. Structural insights into human peroxisome proliferator activated receptor delta (PPAR-delta) selective ligand binding.
Batista FA; Trivella DB; Bernardes A; Gratieri J; Oliveira PS; Figueira AC; Webb P; Polikarpov I
PLoS One; 2012; 7(5):e33643. PubMed ID: 22606221
[TBL] [Abstract][Full Text] [Related]
18. [Selective regulation of peroxisome proliferator-activated receptors on fatty acid binding protein-4 in human syncytiotrophoblast cells].
Li Y; Gu H
Zhonghua Fu Chan Ke Za Zhi; 2012 Oct; 47(10):726-9. PubMed ID: 23302727
[TBL] [Abstract][Full Text] [Related]
19. Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors.
Korbecki J; Bobiński R; Dutka M
Inflamm Res; 2019 Jun; 68(6):443-458. PubMed ID: 30927048
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Blockade of PPAR Isoforms Increases Conditioned Fear Responding in the Presence of Nociceptive Tone.
Gaspar JC; Okine BN; Llorente-Berzal A; Roche M; Finn DP
Molecules; 2020 Feb; 25(4):. PubMed ID: 32102354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
